These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 25921386)

  • 1. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia Stem Cells Microenvironment.
    Tabe Y; Konopleva M
    Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.
    Konopleva M; Tabe Y; Zeng Z; Andreeff M
    Drug Resist Updat; 2009; 12(4-5):103-13. PubMed ID: 19632887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the microenvironment in acute myeloid leukemia.
    Rashidi A; Uy GL
    Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
    Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
    Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
    Hoang VT; Zepeda-Moreno A; Ho AD
    Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow neoplastic niche in leukemia.
    Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
    Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The leukemic stem cell niche: current concepts and therapeutic opportunities.
    Lane SW; Scadden DT; Gilliland DG
    Blood; 2009 Aug; 114(6):1150-7. PubMed ID: 19401558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
    Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
    Front Immunol; 2021; 12():756231. PubMed ID: 34867994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
    Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
    Agarwal P; Bhatia R
    Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential niche and Wnt requirements during acute myeloid leukemia progression.
    Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
    Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and leukemic stem cell niches: insights and therapeutic opportunities.
    Schepers K; Campbell TB; Passegué E
    Cell Stem Cell; 2015 Mar; 16(3):254-67. PubMed ID: 25748932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in understanding the leukaemia microenvironment.
    Tabe Y; Konopleva M
    Br J Haematol; 2014 Mar; 164(6):767-78. PubMed ID: 24405087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.